| Drug
safety advice |
|
•
|
Ciclosporin:
must be prescribed and dispensed by brand name |
|
•
|
Finasteride:
potential risk of male breast cancer |
| Yellow
Card scheme update |
|
•
|
Reporting
of suspected adverse reactions to flu antivirals and flu vaccines |
|
•
|
How
to complete a Yellow Card |
| End-of-year
quiz |
|
•
|
Test
your drug-safety knowledge |
|
Stop
Press
|
|
•
|
Etravirine:
reports of severe hypersensitivity reactions |
|
•
|
Rituximab:
progressive multifocal leukoencephalopathy in a patient without prior
treatment for rheumatoid arthritis |
|
•
|
Warfarin:
product information to be amended to give clearer, up-to-date advice
|
|
•
|
Drug
alert: recall of Gaviscon Advance Peppermint Flavour, Boots Heartburn
Relief Peppermint Flavour, Peptac Peppermint Liquid, and Peptac Liquid
Aniseed Flavour |
| Other
information from the MHRA |
|
•
|
Patient
Information Leaflet of the month: Arthrotec |
| Quiz
answers |
|
•
|
How
did you score? |
